Evidence map›Paper›PMID 32975128›Full record

ArticleIntegrative cancer therapies

Human Biofield Therapy Modulates Tumor Microenvironment and Cancer Stemness in Mouse Lung Carcinoma.

Peiying Yang, Patrea R Rhea, Tara Conway, Sita Nookala, Venkatesh Hegde, Mihai Gagea, Nadim J Ajami, Sean L Harribance, Jewel Ochoa, Jagannadha K Sastry and 1 more

Open access · goldAbstract read
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. The Science of Tai Chi andJournal of integrative and complementary medicine · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Peiying YangThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-4989-6384
Patrea R RheaThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tara ConwayThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sita NookalaThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Venkatesh HegdeThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mihai GageaThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nadim J AjamiThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sean L HarribanceSugarland, TX, USA.
Jewel OchoaThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jagannadha K SastryThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lorenzo CohenThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The University of Texas MD Anderson Cancer Center · USHouston Methodist Sugar Land Hospital · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

Studies have demonstrated that purported biofield therapy emitted from humans can inhibit the proliferation of cancer cells and suppress tumor growth in various cancers. We explored the effects of biofield therapy on tumor growth in the Lewis lung carcinoma and expanded mechanistic outcomes. We found biofield therapy did not inhibit tumor growth. However, the experimental (Ex) condition exposed tumors had a significantly higher percentage of necrosis (24.4 ± 6.8%) compared with that of the Control condition (6.5 ± 2.7%;

Indexed as

CarcinomaLung NeoplasmsAnimalsHumansLungLymphocytes, Tumor-InfiltratingMiceTumor Microenvironmentapoptosisbiofieldimmune modulationLewis lung carcinomastemness

Identifiers

PMID32975128
PMCPMC7522816
OpenAlexW3088300120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.